Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.25% | 64.50% | -337.35% | 23.85% | -2.61% |
| Total Depreciation and Amortization | -20.99% | -4.56% | 0.07% | -8.24% | 3.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.71% | -99.31% | 3,755.87% | 60.72% | 277.32% |
| Change in Net Operating Assets | -247.16% | 883.93% | 111.77% | 32.46% | 12.07% |
| Cash from Operations | 8.84% | -26.57% | -4.99% | 28.76% | 5.23% |
| Capital Expenditure | 87.11% | -7.58% | -75.77% | 81.28% | -336.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -108.78% | -87.12% | 134.56% |
| Cash from Investing | -18.52% | 56.89% | -115.15% | -87.26% | 132.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.79% | -37.80% | 71.72% | 846.04% | 20.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.79% | -37.80% | 71.72% | 846.04% | 20.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.39% | -929.04% | 34.03% | -96.43% | 991.35% |